DBVT:NASDAQ
DBV Technologies SA - ADR
$12.97
arrow_downward
-3.50%(-0.47) 1D
Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBVT...
Open
$13.51
High
$13.51
Low
$12.93
Mkt. cap
831.52M
Avg. vol.
277.58K
Volume
0.00
52-wk high
$26.18
52-wk low
$8.86
EPS
-$3.57
Beta
-0.95
Shares outstanding
62.88M
No. of employees
170
Open
$13.51
High
$13.51
Low
$12.93
Mkt. cap
831.52M
Avg. vol.
277.58K
Volume
0.00
52-wk high
$26.18
52-wk low
$8.86
EPS
-$3.57
Beta
-0.95
Shares outstanding
62.88M
No. of employees
170
News stories
From web sources and news partners
Investing.com
·
16 hours ago
Cantor Fitzgerald reiterates DBV Technologies stock rating at overweight
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA - ADR